Novel Methylated DNA Markers Accurately Discriminate Lynch Syndrome Associated Colorectal Neoplasia

References

• Win AK , JenkinsMA , DowtyJGet al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev.26(3), 404–412 (2017).
   PubMed Web of Science ®Google Scholar
• Boland PM , YurgelunMB , BolandCR. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J. Clin.68(3), 217–231 (2018).
   PubMed Web of Science ®Google Scholar
• Sinicrope FA . Lynch syndrome-associated colorectal cancer. N. Engl. J. Med.379(8), 764–773 (2018).
   PubMed Web of Science ®Google Scholar
• Watson P , VasenHFA , MecklinJPet al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int. J. Cancer123(2), 444–449 (2008).
   PubMed Web of Science ®Google Scholar
• Kastrinos F , StoffelEM. History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin. Gastroenterol. Hepatol.12(5), 715–727 (2014).
   PubMed Web of Science ®Google Scholar
• Moller P , SeppalaTT , BernsteinIet al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut67(7), 1306–1316 (2018).
   PubMed Web of Science ®Google Scholar
• Ahadova A , GallonR , GebertJet al. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int. J. Cancer143(1), 139–150 (2018).
   PubMed Web of Science ®Google Scholar
• Edelstein DL , AxilbundJ , BaxterMet al. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin. Gastroenterol. Hepatol.9(4), 340–343 (2011).
   PubMed Web of Science ®Google Scholar
• Giardiello FM , AllenJI , AxilbundJEet al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Am. J. Gastroenterol.109(8), 1159–1179 (2014).
   PubMed Web of Science ®Google Scholar
• Baxter NN , GoldwasserMA , PaszatLF , SaskinR , UrbachDR , RabeneckL. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med.150(1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Engel C , VasenHF , SeppalaTet al. No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology155(5), 1400–1409 (2018).
   PubMed Web of Science ®Google Scholar
• Kahi CJ , HewettDG , NortonDL , EckertGJ , RexDK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin. Gastroenterol. Hepatol.9(1), 42–46 (2011).
   PubMed Web of Science ®Google Scholar
• Kaminski MF , RegulaJ , KraszewskaEet al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med.362(19), 1795–1803 (2010).
   PubMed Web of Science ®Google Scholar
• Corley DA , JensenCD , MarksARet al. Adenoma detection rate and risk of colorectal cancer and death. N. Engl. J. Med.370(14), 1298–1306 (2014).
   PubMed Web of Science ®Google Scholar
• Giardiello FM , AllenJI , AxilbundJEet al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Dis. Colon. Rectum.57(8), 1025–1048 (2014).
   PubMed Web of Science ®Google Scholar
• Johnson DH , KisielJB , BurgerKNet al. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Gastrointest. Endosc.85(3), 657–665 (2017).
   PubMed Web of Science ®Google Scholar
• Nishihara R , WuK , LochheadPet al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med.369(12), 1095–1105 (2013).
   PubMed Web of Science ®Google Scholar
• Samadder NJ , CurtinK , TuohyTMet al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology146(4), 950–960 (2014).
   PubMed Web of Science ®Google Scholar
• Brenner H , HoffmeisterM , ArndtV , StegmaierC , AltenhofenL , HaugU. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J. Natl. Cancer Inst.102(2), 89–95 (2010).
   PubMedGoogle Scholar
• Newton K , GreenK , LallooF , EvansDG , HillJ. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome. Colorectal. Dis.17(1), 38–46 (2015).
   PubMed Web of Science ®Google Scholar
• Sahnane N , MagnoliF , BernasconiBet al. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clin. Epigenetics7, 131 (2015).
   PubMed Web of Science ®Google Scholar
• Goel A , XicolaRM , NguyenTPet al. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology138(5), 1854–1862 (2010).
   PubMed Web of Science ®Google Scholar
• Kaz A , KimYH , DzieciatkowskiSet al. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int. J. Cancer120(9), 1922–1929 (2007).
   PubMed Web of Science ®Google Scholar
• Chen CH , ShengJiang S , HsiehLLet al. DNA Methylation identifies loci distinguishing hereditary nonpolyposis colorectal cancer without germ-line MLH1/MSH2 mutation from sporadic colorectal cancer. Clin. Transl. Gastroenterol.7(12), e208 (2016).
   PubMedGoogle Scholar
• Lidgard GP , DomanicoMJ , BruinsmaJJet al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin. Gastroenterol. Hepatol.11(10), 1313–1318 (2013).
   PubMed Web of Science ®Google Scholar
• Imperiale TF , RansohoffDF , ItzkowitzSHet al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med.370(14), 1287–1297 (2014).
   PubMed Web of Science ®Google Scholar
• Redwood DG , AsayED , BlakeIDet al. Stool DNA Testing for screening detection of colorectal neoplasia in Alaska native people. Mayo. Clin. Proc.91(1), 61–70 (2016).
   PubMed Web of Science ®Google Scholar
• Sweetser S , AhlquistDA. Multi-target stool DNA test: is the future here?Curr. Gastroenterol. Rep.18(6), 30 (2016).
   PubMedGoogle Scholar
• Ballester V , GiakoumopoulosM , YabTCet al. Sa1921 molecular detection of colorectal neoplasia: do markers that target acquired DNA alterations in sporadic cases also discriminate Lynch syndrome cases? Gastroenterology 148(4), S355 (2015).
   PubMed Web of Science ®Google Scholar
• Kisiel JB , KleppP , AllawiHTet al. Analysis of DNA methylation at specific loci in stool samples detects colorectal cancer and high-grade dysplasia in patients with inflammatory bowel disease. Clin. Gastroenterol. Hepatol.17(5), 914–921 (2019).
   PubMed Web of Science ®Google Scholar
• Taylor WR , KisielJB , YabTCet al. 109 Discovery of novel DNA methylation markers for the detection of colorectal neoplasia: selection by methylome-wide analysis. Gastroenterology146(5), S30 (2014).
   Web of Science ®Google Scholar
• Anderson BW , SuhYS , ChoiBet al. Detection of gastric cancer with novel methylated DNA markers: discovery, tissue validation, and pilot testing in plasma. Clin. Cancer Res.24(22), 5724–5734 (2018).
   PubMed Web of Science ®Google Scholar
• Kisiel JB , RaimondoM , TaylorWRet al. New DNA methylation markers for pancreatic cancer: discovery, tissue validation, and pilot testing in pancreatic juice. Clin. Cancer Res.21(19), 4473–4481 (2015).
   PubMed Web of Science ®Google Scholar
• MethPrimer2.0. (2020). http://www.urogene.org/methprimer2/ (Accessed 15October2015).
   Google Scholar
• Zou H , AllawiH , CaoXet al. Quantification of methylated markers with a multiplex methylation-specific technology. Clin. Chem.58(2), 375–383 (2012).
   PubMed Web of Science ®Google Scholar
• Brikun I , NusskernD , GillenDet al. A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients. Biomark Res.2(1), 25 (2014).
   PubMedGoogle Scholar
• Chaudhary A , HiltonMB , SeamanSet al. TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell21(2), 212–226 (2012).
   PubMed Web of Science ®Google Scholar
• Chen YN , ChenH , XuY , ZhangX , LuoY. Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance. World J. Gastroenterol.14(2), 292–297 (2008).
   PubMed Web of Science ®Google Scholar
• Dai D , WangH , ZhuL , JinH , WangX. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis.9(2), 124 (2018).
   PubMed Web of Science ®Google Scholar
• Hamidov Z , Altendorf-HofmannA , ChenY , SettmacherU , PetersenI , KnoselT. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J. Clin. Pathol.64(11), 990–994 (2011).
   PubMed Web of Science ®Google Scholar
• Knosel T , ChenY , HotovyS , SettmacherU , Altendorf-HofmannA , PetersenI. Loss of desmocollin 1–3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int. J. Colorectal. Dis.27(11), 1391–1399 (2012).
   PubMed Web of Science ®Google Scholar
• Kwok SC , LiuX , MangelP , DaskalI. PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3. DNA Cell Biol.25(9), 523–529 (2006).
   PubMed Web of Science ®Google Scholar
• Liu Y , HydeAS , SimpsonMA , BaryckiJJ. Emerging regulatory paradigms in glutathione metabolism. Adv. Cancer Res.122, 69–101 (2014).
   PubMed Web of Science ®Google Scholar
• Lord RV , BrabenderJ , WickramasingheKet al. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett’s esophagus and Barrett’s-associated adenocarcinoma. Surgery138(5), 924–931 (2005).
   PubMed Web of Science ®Google Scholar
• Lu J , KsendzovskyA , YangCet al. CNTF receptor subunit alpha as a marker for glioma tumor-initiating cells and tumor grade: laboratory investigation. J. Neurosurg.117(6), 1022–1031 (2012).
   PubMedGoogle Scholar
• Nakabayashi M , OsakiM , KodaniIet al. PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia. Oncol. Lett.7(3), 750–754 (2014).
   PubMed Web of Science ®Google Scholar
• Nikitenko LL , LeekR , HendersonSet al. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis. Clin. Cancer Res.19(20), 5740–5748 (2013).
   PubMed Web of Science ®Google Scholar
• Nouguerede E , BerenguerC , GarciaSet al. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo. Cancer Med.2(2), 196–207 (2013).
   PubMed Web of Science ®Google Scholar
• Parris TZ , AzizL , KovacsAet al. Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer14, 324 (2014).
   PubMed Web of Science ®Google Scholar
• Qi DL , OhhiraT , FujisakiCet al. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol. Cell Biol.31(8), 1624–1636 (2011).
   PubMed Web of Science ®Google Scholar
• Ramachandran V , ArumugamT , HwangRF , GreensonJK , SimeoneDM , LogsdonCD. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res67(6), 2666–2675 (2007).
   PubMed Web of Science ®Google Scholar
• Sloane MA , WongJW , PereraDet al. Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia. Epigenetics9(8), 1092–1100 (2014).
   PubMed Web of Science ®Google Scholar
• Wei J , LiG , ZhangJet al. Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer. Oncotarget7(38), 62547–62558 (2016).
   PubMedGoogle Scholar
• Dixit D , XieQ , RichJN , ZhaoJC. Messenger RNA methylation regulates glioblastoma tumorigenesis. Cancer Cell31(4), 474–475 (2017).
   PubMed Web of Science ®Google Scholar
• He L , LiJ , WangXet al. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. J. Cell Mol. Med.22(10), 4630–4639 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang S , ZhaoBS , ZhouAet al. m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell31(4), 591–606 (2017).
   PubMed Web of Science ®Google Scholar
• Bjornstad LG , MezaTJ , OtterleiM , OlafsrudSM , Meza-ZepedaLA , FalnesPO. Human ALKBH4 interacts with proteins associated with transcription. PLoS ONE7(11), e49045 (2012).
   PubMed Web of Science ®Google Scholar
• Fedeles BI , SinghV , DelaneyJC , LiD , EssigmannJM. The AlkB family of Fe(II)/alpha-Ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond. J. Biol. Chem.290(34), 20734–20742 (2015).
   PubMed Web of Science ®Google Scholar
• Ahlquist DA . Universal cancer screening: revolutionary, rational, and realizable. NPJ Precis. Oncol.2, 23 (2018).
   PubMed Web of Science ®Google Scholar
• Qin Y , WuCW , TaylorWRet al. Discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma. Clin. Cancer Res.25(24), 7396–7404 (2019).
   PubMed Web of Science ®Google Scholar
• Kisiel JB , DukekBA , RVSRKet al. Hepatocellular carcinoma detection by plasma methylated DNA: discovery, Phase I pilot, and Phase II clinical validation. Hepatology69(3), 1180–1192 (2019).
   PubMed Web of Science ®Google Scholar
• Bakkum-Gamez JN , KisielJB , SlettedahlSWet al. Discovery and validation of novel DNA methylation markers for the detection of endometrial cancer: selection by methylome-wide analysis. Gynecologic Oncol.154, 71 (2019).
   Web of Science ®Google Scholar
• Peluso MEM , MunniaA , TarocchiMet al. Oxidative DNA damage and formalin-fixation procedures. Toxicol. Res.3(5), 341–349 (2014).
   Web of Science ®Google Scholar
• Keogh LA , NivenH , RutsteinA , FlanderL , GaffC , JenkinsM. Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining. J. Behav. Med.40(4), 583–594 (2017).
   PubMed Web of Science ®Google Scholar
• Leenen CH , HeijerM , VanDer Meer C , KuipersEJ , Van LeerdamME , WagnerA. Genetic testing for Lynch syndrome: family communication and motivation. Fam. Cancer15(1), 63–73 (2016).
   PubMed Web of Science ®Google Scholar
• Heigh RI , YabTC , TaylorWRet al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS One9(1), e85659 (2014).
   PubMed Web of Science ®Google Scholar
• Andersen SH , LykkeE , FolkerMB , BernsteinI , HolckS. Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families. Fam. Cancer7(2), 157–162 (2008).
   PubMed Web of Science ®Google Scholar
• Snover DC . Update on the serrated pathway to colorectal carcinoma. Hum. Pathol.42(1), 1–10 (2011).
   PubMed Web of Science ®Google Scholar